Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib

BACKGROUND: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We examined the degree to which Patient Global Assessment of Disease Activity (PtGA) was driven by patient-reported assessments of pain (Pain), physical function, and fatigue in patients receivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Kaine, Jeffrey, Alten, Rieke, Wallenstein, Gene, Diehl, Annette, Shi, Harry, Germino, Rebecca, Murray, Christopher W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566034/
https://www.ncbi.nlm.nih.gov/pubmed/33059710
http://dx.doi.org/10.1186/s13075-020-02324-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566034/
https://www.ncbi.nlm.nih.gov/pubmed/33059710
http://dx.doi.org/10.1186/s13075-020-02324-7

Ejemplares similares